Alexion to start Soliris in COVID-19 Phase II trial in next few days

Alexion to start Soliris in COVID-19 Phase II trial in next few days: Alexion Pharmaceuticals is revving up to enter the COVID-19 drug development race with Soliris (eculizumab), a drug that is already approved for other indications, a source familiar with the trial told Reynald Castañeda

VARINDIA- INDIA'S FRONTLINE IT MAGAZINE

Comments

Popular posts from this blog

PhysicsWallah transitions to public entity in preparation for 2025 IPO

OpenAI unveils new o3 and o3 mini models, set for 2024 launch